Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe


Join us as at the DIA Japan Annual Meeting 2019, to discuss these topics and the future of healthcare.

Download Program

At DIA, we are here to continue challenging by exerting leadership with a collaboration among industry, government and academia to create a new value in pharmaceutical and medical device development. Needless to say, how to work effectively together is as important as the individual leadership. By maintaining ethics, transparency and fairness, avoiding the conflict of interest and enabling the synergism, a better rational collaboration can be achieved. As a result, our goal is to provide rational medicine with breakthrough innovation to all the current and future people. The 16th DIA Japan Annual Meeting, with a theme of “In Order to Deliver Rational Medicine to all the people in the world,” is a place for discussion, thinking and opinion exchange to contribute to medical environment in the future.

We look forward to welcoming you at Tokyo Big Sight from November 10-12, 2019 for stimulating discussions around promoting better collaboration to drive global health and innovation in this era of medical and scientific transformation.

Program Committee

  • Tatsuya  Kondo, MD, PhD
    Tatsuya Kondo, MD, PhD President
    SH Medical Excellence JAPAN, Japan
  • Takashi  Sato, MSc, PMP
    Takashi Sato, MSc, PMP
    PM Orchestra Takashi Sato, Japan
  • Hiroya  Asou, MD, PhD, MBA
    Hiroya Asou, MD, PhD, MBA Senior Medical Advisor, Global Patient Safety Japan
    Eli Lilly Japan K.K., Japan
  • Noriko  Fujiwara, MS, RN
    Noriko Fujiwara, MS, RN Certified nurse specialist in Cancer Nursing
    IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Japan
  • Yoshikata  Furuya, MSc
    Yoshikata Furuya, MSc Manager, General Affairs Division
    Sankeien Hoshoukai Foundation, Japan
  • Toshinori  Higashi, PhD
    Toshinori Higashi, PhD Vice President, Regulatory Science
  • Kazuo  Ichikawa, PhD, PMP
    Kazuo Ichikawa, PhD, PMP yyy
    Xxx, Japan
  • Katsuhiko  Ichimaru
    Katsuhiko Ichimaru Review Director, Office of New Drug IV
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Toshiko  Ishibashi, PhD, RN
    Toshiko Ishibashi, PhD, RN Oncology Medical Science Department, Medical Affairs Division
    Daiichi Sankyo Co., Ltd., Japan
  • Yoichi M.  Ito, PhD
    Yoichi M. Ito, PhD Director
    Hokkaido University Hospital, Institute of Health Science Innovation, Japan
  • Miyuki  Kaneko
    Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
    Pfizer R&D Japan G.K., Japan
  • Yoko  Kazami, RPh, PMP
    Yoko Kazami, RPh, PMP Director, Regulatory Affairs
    Nobelpharma Co., Ltd., Japan
  • Noriatsu  Kono, MPharm
    Noriatsu Kono, MPharm Organizational management
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Arisa  Maeda
    Arisa Maeda CMC Regulatory Affairs, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Noriaki  Nagao, MPharm, PMP
    Noriaki Nagao, MPharm, PMP Pharmaceutical Division,Clinical Development Dept.
  • Motohide  Nishi, MBA
    Motohide Nishi, MBA Japan Site Leader & VP Professional Services
    Medidata Solutions K.K., Japan
  • Minori  Niso
    Minori Niso Brand Marketing Director, APAC Marketing
    Parexel, Japan
  • Hiromi  Okabe, PhD
    Hiromi Okabe, PhD Immunology, Regulatory Affairs Japan,Global Drug Development Division
    Novartis Pharma K.K, Japan
  • Hiroshi  Sakaguchi
    Hiroshi Sakaguchi Deputy Review Director, Office of New Drug I
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Norio  Shimazaki
    Norio Shimazaki Director, Regional Clinical Operations Japan, Korea and Taiwan
    Bristol-Myers Squibb K.K., Japan
  • Mikiko  Shitara
    Mikiko Shitara Senior Manager, Regulatory Affairs Dept.
    Alexionpharma GK, Japan
  • Kuniko  Shoji
    Kuniko Shoji Vice-Dean, School of Health Innovation
    Kanagawa University of Human Services, Japan
  • Keiko  Tsumori, MSc
    Keiko Tsumori, MSc Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
    MSD K.K., Japan
  • Tadashi  Urashima, PhD
    Tadashi Urashima, PhD Performance and Digital Analytics Lead, Medical & Development Excellence Japan
    GlaxoSmithKline K.K., Japan
  • Manami  Yoshida, DVM
    Manami Yoshida, DVM Associate Director, Medical Affairs – HIV & COVID-19
    Gilead Sciences K.K., Japan
  • Koichiro  Yuji, MD, PhD, FACP
    Koichiro Yuji, MD, PhD, FACP Project Associate Professor, The Institute of Medical Science
  • Kazuhiro  Kanmuri, PhD
    Kazuhiro Kanmuri, PhD Vice President, Product Development and Clinical Operations
    Ascent Development Services Inc, Japan
  • Kazumichi  Kobayashi, RPh
    Kazumichi Kobayashi, RPh Executive Deputy President (Board Member)
    Otsuka Medical Devices Co., Ltd., Japan
  • Junichi  Nishino, MSc, RPh
    Junichi Nishino, MSc, RPh Head, Regulatory Affairs Department
    Otsuka Pharmaceutical Co., Ltd., Japan
  • Hironobu  Saito, PhD
    Hironobu Saito, PhD Specially Appointed Professor
    Tottori University, Chromosome Egineering Research Center, Japan
  • Junko  Sato, PhD
    Junko Sato, PhD Associate Executive Director
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Eri  Sekine
    Eri Sekine Executive Vice President
    CMIC Group, Japan
  • Atsushi  Tsukamoto, PhD, MSc
    Atsushi Tsukamoto, PhD, MSc Head is Therapeutic Area Strategies
    Daiichi Sankyo, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.